Diabetes and cancer II: role of diabetes medications and influence of shared risk factors
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Diabetes and cancer II: role of diabetes medications and influence of shared risk factors
Authors
Keywords
-
Journal
CANCER CAUSES & CONTROL
Volume 23, Issue 7, Pages 991-1008
Publisher
Springer Nature
Online
2012-04-24
DOI
10.1007/s10552-012-9971-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Use of Antidiabetic Agents and the Risk of Pancreatic Cancer: A Case–Control Analysis
- (2012) Michael Bodmer et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Use of Metformin Is Not Associated with a Decreased Risk of Colorectal Cancer: A Case-Control Analysis
- (2012) M. Bodmer et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Mortality After Incident Cancer in People With and Without Type 2 Diabetes: Impact of metformin on survival
- (2012) C. J. Currie et al. DIABETES CARE
- Alcohol, insulin resistance and the liver-brain axis
- (2012) Suzanne de la Monte et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Cancer Prevention With a Diabetes Pill?
- (2012) G. Taubes SCIENCE
- Insulin glargine use and short-term incidence of malignancies — a three-year population-based observation
- (2011) Rickard Ljung et al. ACTA ONCOLOGICA
- Impact of diabetes mellitus on clinical presentation and prognosis of pancreatic cancer
- (2011) Y.M. Dehayem et al. ANNALES D ENDOCRINOLOGIE
- Metformin and thiazolidinediones are associated with improved breast cancer-specific survival of diabetic women with HER2+ breast cancer
- (2011) X. He et al. ANNALS OF ONCOLOGY
- Antitumor effect of orlistat, a fatty acid synthase inhibitor, is via activation of caspase-3 on human colorectal carcinoma-bearing animal
- (2011) Hui-Yen Chuang et al. BIOMEDICINE & PHARMACOTHERAPY
- Troglitazone, a PPAR agonist, inhibits human prostate cancer cell growth through inactivation of NFκB via suppression of GSK-3β expression
- (2011) Jung Ok Ban et al. CANCER BIOLOGY & THERAPY
- Troglitazone suppresses c-Myc levels in human prostate cancer cells via a PPARγ-independent mechanism
- (2011) Tunde O. Akinyeke et al. CANCER BIOLOGY & THERAPY
- Metformin and the Incidence of Prostate Cancer in Patients with Type 2 Diabetes
- (2011) L. Azoulay et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- The insulin receptor substrate (IRS) proteins
- (2011) Leslie M. Shaw CELL CYCLE
- Evaluating Treatment Algorithms for the Management of Patients With Type 2 Diabetes Mellitus: A Perspective on the Definition of Treatment Success
- (2011) Richard B. Aguilar CLINICAL THERAPEUTICS
- Cardiovascular Implications of Antihyperglycemic Therapies for Type 2 Diabetes
- (2011) Fernando Ovalle CLINICAL THERAPEUTICS
- American Diabetes Association Postgraduate Meetings--2011
- (2011) Z. T. Bloomgarden DIABETES CARE
- Cohort Study of Pioglitazone and Cancer Incidence in Patients With Diabetes
- (2011) A. Ferrara et al. DIABETES CARE
- Insulin therapy has a complex relationship with measure of oxidative stress in type 2 diabetes: a case for further study
- (2011) Louis Monnier et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Glucose-lowering agents and the patterns of risk for cancer: a study with the General Practice Research Database and secondary care data
- (2011) T. P. van Staa et al. DIABETOLOGIA
- Diabetes and risk of bladder cancer: a study using the National Health Insurance database in Taiwan
- (2011) C.-H. Tseng DIABETOLOGIA
- Use of metformin and the risk of ovarian cancer: A case–control analysis
- (2011) Michael Bodmer et al. GYNECOLOGIC ONCOLOGY
- AKT down-regulates insulin-like growth factor-1 receptor as a negative feedback
- (2011) Liang Qin et al. JOURNAL OF BIOCHEMISTRY
- Impact of Diabetes Mellitus and Insulin Use on Survival After Colorectal Cancer Diagnosis: The Cancer Prevention Study-II Nutrition Cohort
- (2011) Ahmed N. Dehal et al. JOURNAL OF CLINICAL ONCOLOGY
- The Mediterranean Diet in Cancer Prevention: A Review
- (2011) Niki Kontou et al. JOURNAL OF MEDICINAL FOOD
- Obesity and Women's Health: An Evidence-Based Review
- (2011) T. Kulie et al. Journal of the American Board of Family Medicine
- Overweight, Obesity, Diabetes, and Risk of Breast Cancer: Interlocking Pieces of the Puzzle
- (2011) C. La Vecchia et al. ONCOLOGIST
- The Possible Role of IL-17 in Obesity-Associated Cancer
- (2011) Tiphaine Gislette et al. TheScientificWorldJOURNAL
- The relationship between the exposure time of insulin glargine and risk of breast and prostate cancer: An observational study of the time-dependent effects of antidiabetic treatments in patients with diabetes
- (2011) Marcus Lind et al. Primary Care Diabetes
- Rimonabant-induced apoptosis in leukemia cell lines: Activation of caspase-dependent and -independent pathways
- (2010) Dario Gallotta et al. BIOCHEMICAL PHARMACOLOGY
- Diabetes mellitus and health-related quality of life in prostate cancer: 5-year results from the Prostate Cancer Outcomes Study
- (2010) Melissa S.Y. Thong et al. BJU INTERNATIONAL
- Troglitazone suppresses telomerase activity independently of PPARγ in estrogen-receptor negative breast cancer cells
- (2010) Fariborz Rashid-Kolvear et al. BMC CANCER
- Diabetogenic glucose and insulin concentrations modulate transcriptom and protein levels involved in tumour cell migration, adhesion and proliferation
- (2010) K Masur et al. BRITISH JOURNAL OF CANCER
- Eighteen Insulin-like Growth Factor Pathway Genes, Circulating Levels of IGF-I and Its Binding Protein, and Risk of Prostate and Breast Cancer
- (2010) F. Gu et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Defining the Molecular Nexus of Cancer, Type 2 Diabetes and Cardiovascular Disease
- (2010) S. M. Cabarcas et al. CURRENT MOLECULAR MEDICINE
- Diabetes, Insulin Use, and Cancer Risk: Are Observational Studies Part of the Solution-or Part of the Problem?
- (2010) J. A. Johnson et al. DIABETES
- Comment on: Yang et al. (2010) Associations of Hyperglycemia and Insulin Usage With the Risk of Cancer in Type 2 Diabetes: The Hong Kong Diabetes Registry. Diabetes;59:1254-1260
- (2010) B. Carstensen DIABETES
- Comment on: Yang et al. (2010) Associations of Hyperglycemia and Insulin Usage With the Risk of Cancer in Type 2 Diabetes: The Hong Kong Diabetes Registry. Diabetes;59:1254-1260
- (2010) R. Vigneri et al. DIABETES
- Comment on: Yang et al. (2010) Associations of Hyperglycemia and Insulin Usage With the Risk of Cancer in Type 2 Diabetes: The Hong Kong Diabetes Registry. Diabetes;59:1254-1260
- (2010) D. Simon et al. DIABETES
- Associations of Hyperglycemia and Insulin Usage With the Risk of Cancer in Type 2 Diabetes: The Hong Kong Diabetes Registry
- (2010) X. Yang et al. DIABETES
- Doses of Insulin and Its Analogues and Cancer Occurrence in Insulin-Treated Type 2 Diabetic Patients
- (2010) E. Mannucci et al. DIABETES CARE
- Use of sulphonylurea and cancer in type 2 diabetes—The Hong Kong Diabetes Registry
- (2010) Xilin Yang et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Effect of metformin on oxidative stress, nitrosative stress and inflammatory biomarkers in type 2 diabetes patients
- (2010) Arpita Chakraborty et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Appraising the mitogenicity of insulin analogues relative to human insulin-response to: Weinstein D, Simon M, Yehezkel E, Laron Z, Werner H. Insulin analogues display IGF-I-like mitogenic and anti-apoptotic activity in cultured cancer cells. Diabetes Meta
- (2010) C. Kazda et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Intensive glycaemic control and cancer risk in type 2 diabetes: a meta-analysis of major trials
- (2010) J. A. Johnson et al. DIABETOLOGIA
- Cancer in patients admitted to hospital with diabetes mellitus aged 30 years and over: record linkage studies
- (2010) C. J. Wotton et al. DIABETOLOGIA
- Oxidative stress, inflammation, and cancer: How are they linked?
- (2010) Simone Reuter et al. FREE RADICAL BIOLOGY AND MEDICINE
- Obesity, type 2 diabetes and risk of digestive cancer
- (2010) P. Hillon et al. GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE
- Insulin analogues and cancer risk: cause for concern orcause célèbre?
- (2010) M. Pollak et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- The impact of type 2 diabetes and antidiabetic drugs on cancer cell growth
- (2010) Yin-Hsun Feng et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Energy Balance, Host-Related Factors, and Cancer Progression
- (2010) Stephen D. Hursting et al. JOURNAL OF CLINICAL ONCOLOGY
- Type 2 diabetes mellitus and medications for type 2 diabetes mellitus are associated with risk for and mortality from cancer in a German primary care cohort
- (2010) Dorothee M. Baur et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Metformin in Cancer Therapy: A New Perspective for an Old Antidiabetic Drug?
- (2010) I. Ben Sahra et al. MOLECULAR CANCER THERAPEUTICS
- Type 2 Diabetes and Cancer: What Is the Connection?
- (2010) Dara Cannata et al. MOUNT SINAI JOURNAL OF MEDICINE
- Diabetes and Cancer
- (2010) T. A. Chowdhury QJM-AN INTERNATIONAL JOURNAL OF MEDICINE
- Cancer Statistics, 2009
- (2009) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Alcohol as a Risk Factor for Type 2 Diabetes: A systematic review and meta-analysis
- (2009) D. O. Baliunas et al. DIABETES CARE
- New Users of Metformin Are at Low Risk of Incident Cancer: A cohort study among people with type 2 diabetes
- (2009) G. Libby et al. DIABETES CARE
- Metformin Associated With Lower Cancer Mortality in Type 2 Diabetes: ZODIAC-16
- (2009) G. W.D. Landman et al. DIABETES CARE
- Combined randomised controlled trial experience of malignancies in studies using insulin glargine
- (2009) P. D. Home et al. DIABETOLOGIA
- Insulin glargine use and short-term incidence of malignancies—a population-based follow-up study in Sweden
- (2009) J. M. Jonasson et al. DIABETOLOGIA
- No evidence of increased risk of malignancies in patients with diabetes treated with insulin detemir: a meta-analysis
- (2009) A. Dejgaard et al. DIABETOLOGIA
- Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group
- (2009) H. M. Colhoun et al. DIABETOLOGIA
- The influence of glucose-lowering therapies on cancer risk in type 2 diabetes
- (2009) C. J. Currie et al. DIABETOLOGIA
- Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study
- (2009) L. G. Hemkens et al. DIABETOLOGIA
- Diabetes and cancer
- (2009) Paolo Vigneri et al. ENDOCRINE-RELATED CANCER
- Oxidative Stress, Obesity, and Breast Cancer Risk: Results From the Shanghai Women's Health Study
- (2009) Qi Dai et al. JOURNAL OF CLINICAL ONCOLOGY
- Metformin and Pathologic Complete Responses to Neoadjuvant Chemotherapy in Diabetic Patients With Breast Cancer
- (2009) Sao Jiralerspong et al. JOURNAL OF CLINICAL ONCOLOGY
- Insulin glargine and malignancy: an unwarranted alarm
- (2009) Stuart J Pocock et al. LANCET
- Oxidative stress and metabolic syndrome
- (2009) Christian K. Roberts et al. LIFE SCIENCES
- Sulphonylureas and cancer: a case–control study
- (2008) Matteo Monami et al. ACTA DIABETOLOGICA
- F2-Isoprostanes in Human Health and Diseases: From Molecular Mechanisms to Clinical Implications
- (2008) Samar Basu ANTIOXIDANTS & REDOX SIGNALING
- Genetic Polymorphisms Involved in Insulin-like Growth Factor (IGF) Pathway in Relation to Mammographic Breast Density and IGF Levels
- (2008) C. Diorio et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Phosphorylated Insulin-Like Growth Factor-I/Insulin Receptor Is Present in All Breast Cancer Subtypes and Is Related to Poor Survival
- (2008) J. H. Law et al. CANCER RESEARCH
- Plasma Insulin-like Growth Factors, Insulin-like Binding Protein-3, and Outcome in Metastatic Colorectal Cancer: Results from Intergroup Trial N9741
- (2008) C. S. Fuchs et al. CLINICAL CANCER RESEARCH
- The Perfect Storm: Obesity, Adipocyte Dysfunction, and Metabolic Consequences
- (2008) S. de Ferranti et al. CLINICAL CHEMISTRY
- Rosiglitazone and Risk of Cancer: A meta-analysis of randomized clinical trials
- (2008) M. Monami et al. DIABETES CARE
- Sphingolipids, Insulin Resistance, and Metabolic Disease: New Insights fromin VivoManipulation of Sphingolipid Metabolism
- (2008) William L. Holland et al. ENDOCRINE REVIEWS
- Obesity and Type 2 Diabetes are Associated with an Increased Risk of Developing Cancer and a Worse Prognosis; Epidemiological and Mechanistic Evidence
- (2008) D. LeRoith et al. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
- Insulin, the Insulin-Like Growth Factor Axis, and Mortality in Patients With Nonmetastatic Colorectal Cancer
- (2008) Brian M. Wolpin et al. JOURNAL OF CLINICAL ONCOLOGY
- Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies
- (2008) Andrew G Renehan et al. LANCET
- Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis
- (2008) Jing Ma et al. LANCET ONCOLOGY
- Oxidative stress in environmental-induced carcinogenesis
- (2008) Salvador Mena et al. MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS
- The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level
- (2008) I Ben Sahra et al. ONCOGENE
- Insulin receptor expression by human prostate cancers
- (2008) Michael E. Cox et al. PROSTATE
- Effects of short-term moderate alcohol administration on oxidative stress and nutritional status in healthy males
- (2007) Giovanni Addolorato et al. APPETITE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started